Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity
about
sameAs
Alphavirus-based vaccinesIs There Still Room for Cancer Vaccines at the Era of Checkpoint InhibitorsReplicon RNA Viral Vectors as VaccinesAn Aggressive Hypoxia Related Subpopulation of Melanoma Cells is TRP-2 Negative.Combination of alphavirus replicon particle-based vaccination with immunomodulatory antibodies: therapeutic activity in the B16 melanoma mouse model and immune correlates.Surface display of glycosylated Tyrosinase related protein-2 (TRP-2) tumour antigen on Lactococcus lactis.HSP70i is a critical component of the immune response leading to vitiligoEnhancement of humoral and cell mediated immune response to HPV16 L1-derived peptides subsequent to vaccination with prophylactic bivalent HPV L1 virus-like particle vaccine in healthy females.Genetic cancer vaccines: current status and perspectives.Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine.Nanoscale assemblies and their biomedical applications.RNA-based drugs and vaccines.Self-replicating alphavirus RNA vaccines.Protein Expression Analysis of Melanocyte Differentiation Antigen TRP-2.Alphavirus-based vaccines in melanoma: rationale and potential improvements in immunotherapeutic combinations.Different applications of virus-like particles in biology and medicine: Vaccination and delivery systems.Enhancing Immune Responses to Cancer Vaccines Using Multi-Site Injections.Prospect and progress of personalized peptide vaccinations for advanced cancers.Semliki Forest virus biodistribution in tumor-free and 4T1 mammary tumor-bearing mice: a comparison of transgene delivery by recombinant virus particles and naked RNA replicon.Mechanism of action of mRNA-based vaccines.Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells.Trial Watch: DNA vaccines for cancer therapy.Alphavirus-Based Vaccines.Alphavirus-Based Vaccines.
P2860
Q26994724-451D3116-6416-4BD4-9F7B-27347253B712Q28072532-06706960-2879-48E2-8760-3DB86C39BE47Q28076639-6E6FBF4C-61A1-4FFF-AC9E-382668921838Q35152524-6E80F7B2-8E20-4634-9B0E-62E64149709CQ35527105-4F5D44F9-18D6-4241-8F10-79944565DD50Q35881190-3890D4C4-A5E7-46CA-A40E-D1E388BF6244Q36871508-95C4CDA1-13FC-4B9D-BEFD-31AFB56F6E14Q37735000-4225D2F7-2EAA-4AB0-81F5-010D34BF67ACQ38009352-7FB32019-19EA-468F-8FEA-889010291FC3Q38063819-1442CDEC-A04A-48DA-AAC0-ADA020F274FFQ38072847-E220F51E-22A0-42D4-B2AF-D03DF5781B88Q38249163-01108B28-17AB-478E-B0D9-8222D20EDEC1Q38255634-43FA10CB-0B4D-4C51-9A3C-7926F02DB7E6Q38382073-8E6C2844-15AC-40D3-AAF7-A75B949790AFQ38574574-CDA4344B-C2D9-4E3E-8566-4D387AAB0799Q38618258-3AE89CD6-59F4-489B-A8AC-238C78461F98Q38641485-BC58CD01-402A-4DDB-A2B0-7AE82D63444BQ38758988-BCDC6B76-A90A-44DC-A368-D5BADF0D5388Q39327107-377AD5DE-A763-4D90-AFFE-EE6FECC66A9DQ39431058-868656F8-ED63-4D33-8A3F-876CB8FB0FE0Q40099497-7595D284-6C87-4F81-B758-E85FC3395079Q42552005-3B276269-A0A5-4D52-9B8D-956D0BDF8ACBQ50870504-15E53AA6-47DF-49DD-8EA8-463B75D2FC06Q51072912-3593E74B-B9D9-4137-B1F1-F2008B7C3CB1
P2860
Alphavirus replicon particles expressing TRP-2 provide potent therapeutic effect on melanoma through activation of humoral and cellular immunity
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Alphavirus replicon particles ...... humoral and cellular immunity
@ast
Alphavirus replicon particles ...... humoral and cellular immunity
@en
Alphavirus replicon particles ...... humoral and cellular immunity
@nl
type
label
Alphavirus replicon particles ...... humoral and cellular immunity
@ast
Alphavirus replicon particles ...... humoral and cellular immunity
@en
Alphavirus replicon particles ...... humoral and cellular immunity
@nl
prefLabel
Alphavirus replicon particles ...... humoral and cellular immunity
@ast
Alphavirus replicon particles ...... humoral and cellular immunity
@en
Alphavirus replicon particles ...... humoral and cellular immunity
@nl
P2093
P2860
P1433
P1476
Alphavirus replicon particles ...... humoral and cellular immunity
@en
P2093
Alan N Houghton
Daniel Hirschhorn-Cymerman
Erika Ritter
Francesca Avogadri
Jedd D Wolchok
John Morris
Maureen F Maughan
Robert Olmsted
Taha Merghoub
P2860
P304
P356
10.1371/JOURNAL.PONE.0012670
P407
P577
2010-09-10T00:00:00Z